⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of PSI CRO and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
PSI CRO
↗Zug, Switzerland
PSI CRO is a global, full-service contract research organization (CRO) founded in 1995. It is recognized as the only fully independent and privately owned mid-sized global CRO, operating in over 50 countries with a strong focus on on-time delivery of clinical trials and predictable patient enrollment.
The company specializes in pivotal Phase 2 and Phase 3 clinical trials across various therapeutic areas, including oncology, hematology, gastroenterology, autoimmune diseases, infectious diseases, and neurology. PSI is known for its expertise in complex trial designs, such as platform and umbrella designs, as well as precision medicine, targeted immunotherapy, radiopharmaceuticals, and cell and gene therapies.
CLASSIFICATION
SIZE & FINANCIALS
Employees:1001-5000
Founded:1995
Ownership:private
Status:operating
PIPELINE
Stage:Commercial
Lead Drug Stage:N/A (Service Provider)
Modalities:Small molecule, Immunotherapy, Radiopharmaceuticals, Cell therapy, Gene therapy
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:PSI Pharma Support America Inc., PSI CRO D.O.O., PSI CRO UK Limited, PSI CRO Latvia SIA
Key Partnerships:Global pharmaceutical and biotech sponsors
COMPETITION
Position:Leader
Competitors:TFS, Parexel, Syneos Health
LEADERSHIP
Key Executives:
Nick Sinackevich - CEO
Scientific Founders:Dr. Robert Reekie, Dr. Roger A. Smith
LINKS
Website:psi-cro.com
LinkedIn:LinkedIn Profile
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with PSI CRO. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.